Targeted inhibition of the COP9 signalosome for treatment of cancer
about
Murine Myocardial Transcriptome Analysis Reveals a Critical Role of COPS8 in the Gene Expression of Cullin-RING Ligase Substrate Receptors and Redox and Vesicle Trafficking Pathways.SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase functionFrontiers in Medicinal Chemistry 2017 in Bern, Switzerland.CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.Prospect of divergent roles for the CUL3 system in vascular endothelial cell function and angiogenesis.Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.The COP9 signalosome inhibits Cullin-RING E3 ubiquitin ligases independently of its deneddylase activity.The COP9 Signalosome regulates seed germination by facilitating protein degradation of RGL2 and ABI5.Biology in Bloom: A Primer on the Arabidopsis thaliana Model System.Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.Interaction between parasite-encoded JAB1/CSN5 and macrophage migration inhibitory factor proteins attenuates its proinflammatory function.Computational Studies on the Inhibitor Selectivity of Human JAMM Deubiquitinylases Rpn11 and CSN5Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5
P2860
Q38598847-82207228-D4DC-402A-A220-D6A358A1AA73Q42009353-3BCBEE2D-0419-40CD-A9FE-1A56DD48AC26Q47262276-F93B88B4-925D-491B-91BF-FC5145D00F70Q47347572-48DC9FEF-326A-4391-A8BA-5A428A85EDD1Q47619828-9C94BC59-1616-470C-B233-26F150E9D8C9Q47692259-3ED771D8-7C9C-49B4-ACEE-D317FF94B685Q48146730-3192C130-B734-48F3-B017-AB08F9E44C73Q49887000-163AF6AA-5D20-451D-B04E-64487158A769Q50422504-746CA2C9-62C5-4A7E-A309-1CBDB33A8359Q52606514-FB70117D-3119-4677-8ECA-91C4A08FF6BFQ52657204-4F094DCA-CE2E-472F-B24F-0012F19CF525Q52715760-C94A5E1E-1802-4FEB-ABB5-512EB8FC269DQ55690843-098416F3-2877-4892-BE41-DBD7C7882853Q57816614-55BE472C-2022-4D11-BBB8-5970545FF2A0Q59284841-18FD8BEC-0D82-4198-B4DD-5D917550CACD
P2860
Targeted inhibition of the COP9 signalosome for treatment of cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted inhibition of the COP9 signalosome for treatment of cancer
@en
Targeted inhibition of the COP9 signalosome for treatment of cancer.
@nl
type
label
Targeted inhibition of the COP9 signalosome for treatment of cancer
@en
Targeted inhibition of the COP9 signalosome for treatment of cancer.
@nl
prefLabel
Targeted inhibition of the COP9 signalosome for treatment of cancer
@en
Targeted inhibition of the COP9 signalosome for treatment of cancer.
@nl
P2093
P2860
P356
P1476
Targeted inhibition of the COP9 signalosome for treatment of cancer
@en
P2093
Andreas Weiss
Anita Schlierf
Anne B Jefferson
Bruno Martoglio
Eva Altmann
Jean Quancard
Martin Renatus
Matthew Jones
Michael Kiffe
P2860
P2888
P356
10.1038/NCOMMS13166
P407
P577
2016-10-24T00:00:00Z